One of the most studied oncomiRs, miR‐21 targets and suppresses the expression of tumor‐suppressor genes such as PTEN and PDCD4 that activate the PI3K/AKT pathway promoting cell survival, proliferation, and growth [95]. The gene discussed is PTEN; the disease is neoplasm.